Details for New Drug Application (NDA): 070583

NDA 070583 describes BUPIVACAINE HYDROCHLORIDE, which is a drug marketed by Aspiro, Civica, Eugia Pharma, Hikma Pharms, Hospira, Meitheal, Somerset, Steriscience Speclts, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, and Intl Medicated, and is included in thirty-four NDAs. It is available from eighteen suppliers. Additional details are available on the BUPIVACAINE HYDROCHLORIDE profile page.

The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.

Summary for 070583

Tradename:	BUPIVACAINE HYDROCHLORIDE
Applicant:	Hospira
Ingredient:	bupivacaine hydrochloride
Patents:	0

Pharmacology for NDA: 070583

Physiological Effect

Local Anesthesia

Suppliers and Packaging for NDA: 070583

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BUPIVACAINE HYDROCHLORIDE	bupivacaine hydrochloride	INJECTABLE;INJECTION	070583	ANDA	Hospira, Inc.	0409-1159	0409-1159-10	25 VIAL, SINGLE-DOSE in 1 TRAY (0409-1159-10) / 30 mL in 1 VIAL, SINGLE-DOSE (0409-1159-09)
BUPIVACAINE HYDROCHLORIDE	bupivacaine hydrochloride	INJECTABLE;INJECTION	070583	ANDA	Hospira, Inc.	0409-1159	0409-1159-01	25 VIAL, SINGLE-DOSE in 1 TRAY (0409-1159-01) / 10 mL in 1 VIAL, SINGLE-DOSE (0409-1159-18)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	0.25%
Approval Date:	Feb 17, 1987	TE:	AP	RLD:	No

Complete Access Available with Subscription